Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Wang, Yanga; 1 | He, Bob; 1 | Dong, Yanc | He, Gong-Jingd | Qi, Xiao-Weie | Li, Yanf | Yang, Yi-Feia | Rao, Yua | Cen, Zhong-Shuna | Han, Feig; * | Ding, Junh; * | Li, Jian-Junc; *
Affiliations: [a] Department of Pediatrics, Southwest Hospital, Army Medical University, Chongqing, China | [b] Department of Thoracic Surgery, Southwest Hospital, Army Medical University, Chongqing, China | [c] Department of Oncology, Southwest Hospital, Army Medical University, Chongqing, China | [d] Department of Otolaryngology, Southwest Hospital, Army Medical University, Chongqing, China | [e] Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing, China | [f] Chongqing University Cancer Hospital, Chongqing, China | [g] Institute of Toxicology, College of Preventive Medicine, Army Medical University, Chongqing, China | [h] Department of Hepatobiliary Surgery, Third Affiliated Hospital of Chongqing Medical University, Chongqing, China
Correspondence: [*] Corresponding authors: Fei Han, Jun Ding and Jian-Jun Li, No. 30, Gaotanyan Street, Shapingba District, Chongqing 400038, China. %****␣cbm-31-cbm200540_temp.tex␣Line␣125␣**** Tel.: +86 23 68772390 and +86 23 68765193; Fax: +86 23 65425219; E-mail: flysky@tmmu.edu.cn/han16897723@163.com(FeiHan),2223407767@QQ.com(JunDing)andjianjunli@tmmu.edu.cn(Jian-JunLi).
Note: [1] Co-first authors.
Abstract: BACKGROUND: The prognosis of lung cancer patients is poor without useful prognostic and diagnostic biomarker. To search for novel prognostic and diagnostic markers, we previously found homeobox-A13 (HOXA13) as a promising candidate in lung cancer. OBJECTIVE: To determine the precisely clinical feature, prognostic and diagnostic value, possible role and mechanism of HOXA13. METHODS: Gene-expression was explored by real-time quantitative-PCR, western-blot and tissue-microarray. The associations were analyzed by Chi-square test, Kaplan-Meier and Cox-regression. The roles and mechanisms were evaluated by MTS, EdU, transwell, xenograft tumor and luciferase-reporter assays. RESULTS: HOXA13 expression is increased in tumors, and correlated with age of patients. HOXA13 expression is associated with unfavorable overall survival and relapse-free survival of patients in four cohorts. Interestingly, HOXA13 has different prognostic significance in adenocarcinoma (ADC) and squamous-cell carcinoma (SCC), and is a sex- and smoke-related prognostic factor only in ADC. Importantly, HOXA13 can serve as a diagnostic biomarker for lung cancer, especially for SCC. HOXA13 can promote cancer-cell proliferation, migration and invasion in vitro, and facilitate tumorigenicity and tumor metastasis in vivo. HOXA13 acts the oncogenic roles on tumor growth and metastasis by regulating P53 and Wnt/β-catenin signaling activities in lung cancer. CONCLUSIONS: HOXA13 is a new prognostic and diagnostic biomarker associated with P53 and Wnt/β-catenin signaling pathways.
Keywords: Overall survival, diagnostic marker, homeobox-A13, oncogene, P53 signaling, Wnt/β-catenin signaling, non-small cell lung cancer
DOI: 10.3233/CBM-200540
Journal: Cancer Biomarkers, vol. 31, no. 3, pp. 239-254, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl